We are a consumer driven, pharma company, devoted to research and development of beneficial products based on our Buccal Extended Release Drug Delivery System.
We develop innovative drug products for treatment of widespread diseases that currently do not have satisfactory solutions. We design our products to optimize their efficiency, their specificity with safety and regulation profiles and optimal patient compliance.
MBA, 25 years of experience as entrepreneur in food development.
Specializes in user compliance and consumer decision making.
Highly experienced in operating and managing under high uncertainty.
Experienced in developing new consumer goods concepts and introducing new products to the market.
Partner, Investor relations
Partner, Chemistry and Cannabis
Organic Chemist expert in innovation in the life science sector. As Director of Life Science of T3 (Tech. transfer office of the Technicon) he set up Companies like Nano-Ghost and Cannasoul.
He is the founder of Mental Heal, a company that develops a drug for the negative symptoms of schizophrenia and Glaucopharm, a company dealing with the treatment for Glaucoma.
Partner, Oral germs and Clinical Trails
BSc. MED in 2005, DMD in 2007, MPH in 2012, Ph.D. In 2020 from the Hebrew University – Faculty of Dentistry in Hadassah. Doctor of Dentistry, research and technology consultant for dental and pharma startups.
Member of the Faculty of Dentistry and Head of Dental Research, Hadassah University. Currently serves as the President of the Israel Society for Public Health in Israel.
Partner, Regulation and Toxicology
Expert in the regulation of toxicology. Pre-clinical development and safety assessment of innovative drugs, chemicals and food ingredients.
Over 20 years in the field of regulatory toxicology. Worked in Teva, Agis, Perrigo, Padgis and several Startup companies. Serves as Head of Preclinical Development and Toxicology at Perrigo/Padagis since 2003 to date.
World leader in Buccal Drug Delivery market